Bio-Key IntlBKYI

13F holders, Q2 2024 (June 30)
10holders +2
3new positions
1sold out
$1.64avg. 13F price*

At the end of Q2 2024, 10 institutions reported holding Bio-Key Intl Inc. (BKYI) in their 13F filings, up 2 from Q1 2024. 3 opened new positions and 1 sold out. The largest holders were Geode Capital Management, LLC ($20K), Tower Research Capital LLC (TRC) ($10K) and UBS Group AG ($4K).

Company
Bio-Key Intl Inc.
CUSIP
09060C507
Latest filing quarter
Q1 2026

History

Number of 13F holders

051015 Q1 2024: 8Q1 2024Q2 2024: 10Q2 2024Q3 2024: 11Q3 2024Q4 2024: 13Q4 2024Q1 2025: 13Q1 2025Q2 2025: 10Q2 2025Q3 2025: 11Q3 2025Q4 2025: 14Q4 2025Q1 2026: 9Q1 2026

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions3$20K
Exits1$695

All 13F filers, Q1 2024 → Q2 2024: 15,317 shares bought and 1,250 shares sold, net +14,067 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 10 holders

Geode Capital Management, LLC 0.00% New 12,108 $20K
Tower Research Capital LLC (TRC) 0.00% Add +25.0% 5,920 $10K
UBS Group AG 0.00% Add +454.6% 2,446 $4K
Osaic Holdings, Inc. 0.00% Reduce -73.8% 262 $429
JPMorgan Chase & Co. 0.00% Reduce -70.5% 71 $116
Abich Financial Wealth Management LLC 0.00% No change 37 $61
Bank of America Corp. 0.00% New 14 $23
Harbour Investments, Inc. 0.00% New 6 $10
NewEdge Advisors, LLC 0.00% No change 4 $7
Wells Fargo & Company 0.00% Reduce -70.0% 3 $5

"% of holder's portfolio" is BKYI's weight in each manager's 13F, not the share of Bio-Key Intl Inc. the manager owns.